Clinical Trial Update: Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study

View source ↗

Summary

A clinical trial at University Hospital Schleswig-Holstein is recruiting for a study investigating prodromal alpha-synuclein screening in Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Parkinson Disease | Status: RECRUITING